Sign Up Now to Download a Free Research Report on CYCC
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals shares declined 13.54 percent on volume of 2.58 million shares traded to close at $3.00 a share. The company announced the pricing of an underwritten offering of 6,666,667 shares of its common stock at $3.00 per share.
Going forward ... (see research report)
Subscribe to News Feeds